Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Rasmussen

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|November 7, 2012
A soy, whey and caseinate blend extends postprandial skeletal muscle protein synthesis in ratsD N Butteiger, M Cope, P Liu, et al.
Breast Cancer Research and Treatment|August 3, 2017
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98S Alkner, M-B Jensen, B B Rasmussen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assaysJ Andersen, S M Thorpe, W J King, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent diseaseA E Lykkesfeldt, I Balslev, I J Christensen, et al.
Cancer Research|August 1, 1986
Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancerE R DeSombre, S M Thorpe, C Rose, et al.
Lancet (London, England)|January 5, 1985
Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor valuesC Rose, S M Thorpe, K W Andersen, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 7, 2001
Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exerciseK D Tipton, B B Rasmussen, S L Miller, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 CH T Mouridsen, C Rose, M Overgaard, et al.
Cancer Research|November 1, 1989
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancerS M Thorpe, H Rochefort, M Garcia, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Classical prognostic factors in node-negative breast cancer: the DBCG experienceH T Mouridsen, J Andersen, K W Andersen, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical Nutrition (Edinburgh, Scotland)|November 7, 2012
A soy, whey and caseinate blend extends postprandial skeletal muscle protein synthesis in ratsD N Butteiger, M Cope, P Liu, et al.
Breast Cancer Research and Treatment|August 3, 2017
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98S Alkner, M-B Jensen, B B Rasmussen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assaysJ Andersen, S M Thorpe, W J King, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent diseaseA E Lykkesfeldt, I Balslev, I J Christensen, et al.
Cancer Research|August 1, 1986
Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancerE R DeSombre, S M Thorpe, C Rose, et al.
Lancet (London, England)|January 5, 1985
Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor valuesC Rose, S M Thorpe, K W Andersen, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 7, 2001
Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exerciseK D Tipton, B B Rasmussen, S L Miller, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 CH T Mouridsen, C Rose, M Overgaard, et al.
Cancer Research|November 1, 1989
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancerS M Thorpe, H Rochefort, M Garcia, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Classical prognostic factors in node-negative breast cancer: the DBCG experienceH T Mouridsen, J Andersen, K W Andersen, et al.
Pageof 9